Curetis

  • Develops a point-of-care (POC) rapid diagnostic system for pathogens and antibiotic-resistant biomarkers in hospital settings using a multiplexed polymerase chain reaction (PCR) technique
  • Curetis has developed two platforms, the Unyvero A50 (currently on the market) and the Unyvero A30 RQ (sche...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Molzym

Company Profile | June 17, 2021

Molzym was founded by Michael Lorenz in 2003 and was acquired by Gradian Diagnostics in December 2019 The company's core technology is a culture‑free enrichment method for bacterial and fungal DNA, which it sells as a kit or different components of the kit as needed by the end user It also ... Not part of subscription

SnapDNA

Company Profile | May 13, 2022

​​​​​Develops a rapid pathogen detection platform,TrueRapid; the system works by selectively capturing only live pathogenic bacteria cells by binding to aptamers Claims the system is capable of delivering quantitative analysis for the presence of food pathogens in 20 minutes and reducing the ... Not part of subscription

SwissDeCode

Company Profile | April 06, 2022

Developer of DNAFoil, B3, and BEAMitup — rapid DNA tests for food authentication and compliance; intends to sell compliance‑as‑a‑service via BEAMitup and ISO17025 certificates Company utilizes library of 200,000 unique DNA fingerprints to create onsite DNA tests with results in 30 minutes ... Not part of subscription